Skip to main content
Top
Published in: Rheumatology International 11/2006

01-09-2006 | Original Article

Raynaud’s Syndrome: comparison of late and early onset forms using hand perfusion scintigraphy

Authors: Z. Csiki, L. Galuska, I. Garai, N. Szabó, J. Varga, Cs. András, M. Zeher

Published in: Rheumatology International | Issue 11/2006

Login to get access

Abstract

Primary Raynaud’s disease is generally a disease of younger females; however, there are cases where symptoms present over the age of 40. These cases are described as late onset. In our current prospective study we compared the characteristics of early and late onset types of primary Raynaud’s in 127 patients. In addition to the collection of medical records, we performed capillary-microscopy and hand perfusion scintigraphy using Tc-99 m DTPA to evaluate the microcirculation of each patient’s fingers. Regarding the spectrum of the capillary-microscopic findings, we did not find any significant difference between the early and late onset forms. However, in hand perfusion examinations done using Tc-99 m DTPA, we measured a significantly lower finger/palm ratio (FPR) in the early onset group of patients. We also observed a correlation between the duration of the disease and the FPR, as well as between the age and FPR. Longer disease duration resulted in a significantly lower FPR. On the basis of our results, we believe that late onset Raynaud’s should be treated as a separate entity. Due to its different characteristics found on examination and follow-up of our patients, functional hand perfusion examination should be recommended independently of the age-related characteristics of the disease.
Literature
1.
go back to reference De Angelis R, Del Medico P, Blasetti P, Cervini C (2003) Raynaud’s phenomenon: clinical spectrum of 118 patients. Clin Rheumatol 22:279–184CrossRefPubMed De Angelis R, Del Medico P, Blasetti P, Cervini C (2003) Raynaud’s phenomenon: clinical spectrum of 118 patients. Clin Rheumatol 22:279–184CrossRefPubMed
2.
go back to reference Ling SM, Wigley FM (1999) Raynaud’s phenomenon in older adults: diagnostic considerations and management. Drugs Aging 15:183–195CrossRefPubMed Ling SM, Wigley FM (1999) Raynaud’s phenomenon in older adults: diagnostic considerations and management. Drugs Aging 15:183–195CrossRefPubMed
3.
go back to reference Planchon B, Pistorius MA, Beurrier P, De Faucal P (1994) Primary Raynaud’s phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients. Angiology 45:677–686PubMed Planchon B, Pistorius MA, Beurrier P, De Faucal P (1994) Primary Raynaud’s phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients. Angiology 45:677–686PubMed
4.
go back to reference Blockmans D, Beyens G, Verhaeghe R (1996) Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases. Clin Rheumatol 15:148–153CrossRefPubMed Blockmans D, Beyens G, Verhaeghe R (1996) Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases. Clin Rheumatol 15:148–153CrossRefPubMed
5.
go back to reference Czirjak L, Nagy Z (2003) Importance of Raynaud’s phenomenon in the connective tissue diseases. Hun Immunol/Magy Immunol 2:21–25 Czirjak L, Nagy Z (2003) Importance of Raynaud’s phenomenon in the connective tissue diseases. Hun Immunol/Magy Immunol 2:21–25
6.
go back to reference Galuska L, Garai I, Csiki Z, Varga J, Bodolay E, Bajnok L (2000) The clinical usefulness of the fingers-to-palm ratio in different hand microcirculatory abnormalities. Nucl Med Commun 21:659–663CrossRefPubMed Galuska L, Garai I, Csiki Z, Varga J, Bodolay E, Bajnok L (2000) The clinical usefulness of the fingers-to-palm ratio in different hand microcirculatory abnormalities. Nucl Med Commun 21:659–663CrossRefPubMed
7.
go back to reference Riera G, Vilardell M, Vaque J, Fonollosa V, Bermejo B (1993) Prevalence of Raynaud’s phenomenon in a healthy Spanish population. J Rheumatol 20:66–69PubMed Riera G, Vilardell M, Vaque J, Fonollosa V, Bermejo B (1993) Prevalence of Raynaud’s phenomenon in a healthy Spanish population. J Rheumatol 20:66–69PubMed
9.
go back to reference Korn JH (2000) Raynaud’s phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes. Curr Opin Rheumatol 12:509–510CrossRefPubMed Korn JH (2000) Raynaud’s phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes. Curr Opin Rheumatol 12:509–510CrossRefPubMed
10.
go back to reference Cerinic MM, Generini S, Pignone A (1997) New approaches to Raynaud’s phenomenon [corrected]. Curr Opin Rheumatol 9:544–556PubMedCrossRef Cerinic MM, Generini S, Pignone A (1997) New approaches to Raynaud’s phenomenon [corrected]. Curr Opin Rheumatol 9:544–556PubMedCrossRef
11.
go back to reference Nagy Z, Czirjak L (2004) Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud’s disease. J Eur Acad Dermatol Venereol 8:62–68CrossRef Nagy Z, Czirjak L (2004) Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud’s disease. J Eur Acad Dermatol Venereol 8:62–68CrossRef
13.
go back to reference Anders HJ, Sigl T, Schattenkirchner M (2001) Differentiation between primary and/ secondary Raynaud’s phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope. Ann Rheum Dis 60:407–409CrossRefPubMed Anders HJ, Sigl T, Schattenkirchner M (2001) Differentiation between primary and/ secondary Raynaud’s phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope. Ann Rheum Dis 60:407–409CrossRefPubMed
14.
go back to reference Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M, Seriolo B, Sulli A (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 43:719–726CrossRefPubMed Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M, Seriolo B, Sulli A (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 43:719–726CrossRefPubMed
16.
go back to reference Onder M, Ozden MG, Aksakal AB, Akcali D, Babacan A, Atasever T (2002) Raynaud phenomenon and Behcet disease: diagnosis with technetium Tc 99 m methylene diphosphonate bone scan and treatment with continuous sympathetic block. Arch Dermatol 138:698–699CrossRefPubMed Onder M, Ozden MG, Aksakal AB, Akcali D, Babacan A, Atasever T (2002) Raynaud phenomenon and Behcet disease: diagnosis with technetium Tc 99 m methylene diphosphonate bone scan and treatment with continuous sympathetic block. Arch Dermatol 138:698–699CrossRefPubMed
17.
go back to reference Seitz WS, Kline HJ, McIlroy MB (2001) Quantitative assessment of peripheral arterial obstruction in Raynaud’s phenomenon: development of a predictive model of obstructive arterial cross-sectional area and validation with a Doppler blood flow study. Angiology 51:985–998CrossRef Seitz WS, Kline HJ, McIlroy MB (2001) Quantitative assessment of peripheral arterial obstruction in Raynaud’s phenomenon: development of a predictive model of obstructive arterial cross-sectional area and validation with a Doppler blood flow study. Angiology 51:985–998CrossRef
18.
go back to reference Keberle M, Tony HP, Jahns R, Hau M, Haerten R, Jenett M (2000) Assessment of microvascular changes in Raynaud’s phenomenon and connective tissue disease using colour doppler ultrasound. Rheumatology 39:1206–1213CrossRefPubMed Keberle M, Tony HP, Jahns R, Hau M, Haerten R, Jenett M (2000) Assessment of microvascular changes in Raynaud’s phenomenon and connective tissue disease using colour doppler ultrasound. Rheumatology 39:1206–1213CrossRefPubMed
19.
go back to reference Garai I, Csiki Z, Szűcs G, Varga I, Galuska L (2003) Visualizing the effect of pentoxyphyllin infusion therapy on the circulation of the hand by Tc-99 m DTPA scintgraphy. Clin Nucl Med 28:611–612CrossRefPubMed Garai I, Csiki Z, Szűcs G, Varga I, Galuska L (2003) Visualizing the effect of pentoxyphyllin infusion therapy on the circulation of the hand by Tc-99 m DTPA scintgraphy. Clin Nucl Med 28:611–612CrossRefPubMed
Metadata
Title
Raynaud’s Syndrome: comparison of late and early onset forms using hand perfusion scintigraphy
Authors
Z. Csiki
L. Galuska
I. Garai
N. Szabó
J. Varga
Cs. András
M. Zeher
Publication date
01-09-2006
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 11/2006
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-006-0121-8

Other articles of this Issue 11/2006

Rheumatology International 11/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.